Rare diseases
Investigational molecules
Locations
Study of Lutetium (177Lu) Oxodotreotide for Patients with Recurrent Meningioma Without Surgery or Radiotherapy Options
AustriaStudy on Hydroxycarbamide Tablets for Children with Sickle Cell Disease
FranceStudy on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayComparison of ruxolitinib versus hydroxycarbamide or interferon alfa as first treatment for high-risk polycythemia vera patients
FranceStudy Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera
AustriaStudy on Hydroxyurea and Valproic Acid or 6-Mercaptopurine with Valproic Acid for Patients with Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NorwayA study of hydroxyurea added to standard drug combination to assess safety and effectiveness in adults with relapsed or refractory acute myeloid leukemia
SwedenStudy on Improving Treatment for Sickle Cell Disease Patients Using Hydroxycarbamide
FranceStudy Comparing Bomedemstat and Hydroxycarbamide for Patients with Essential Thrombocythemia
AustriaStudy of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors
BulgariaStudy on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia
SwedenStudy Comparing Fedratinib with Drug Combination for Myelofibrosis in Patients Previously Treated with Ruxolitinib
AustriaTell us about your condition – we search every trial in Europe and connect you with the right site.
